CURRENT CHEMOTHERAPY AND FUTURE-DIRECTIONS IN RESEARCH FOR THE TREATMENT OF ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER

被引：53

作者：

KREIS, W

机构：

[1] Department of Medicine, North Shore University Hospital Cornell University Medical College, Manhasset, NY, 11030

来源：

关键词：

D O I：

10.3109/07357909509094465

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：296 / 312

页数：17

共 155 条

[111] RECCHIA F, 1993, P AACR, V32, P204
[112] Robinson R G, 1989, Radiographics, V9, P271
[113] ROSSOF AH, 1979, CANCER TREAT REP, V63, P1579
[114] ROTH B, 1992, P AN M AM SOC CLIN, V11, P196
[115] SAXMAN S, 1991, CANCER, V15, P2488
[116] PHASE-II TRIAL OF DOXORUBICIN IN BIDIMENSIONALLY MEASURABLE PROSTATIC ADENOCARCINOMA
SCHER, H
YAGODA, A
WATSON, RC
SERBER, M
WHITMORE, W
[J]. JOURNAL OF UROLOGY, 1984, 131 (06) : 1099 - 1102
[117] FLUTAMIDE WITHDRAWAL SYNDROME - ITS IMPACT ON CLINICAL-TRIALS IN HORMONE-REFRACTORY PROSTATE-CANCER
SCHER, HI
KELLY, WK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) : 1566 - 1572
[118] SCHER HI, 1987, CANCER TREAT REP, V71, P887
[119] METHYLGLYOXAL-BIS(GUANYLHYDRAZONE) IN HORMONE-RESISTANT ADENOCARCINOMA OF THE PROSTATE
SCHER, HI
YAGODA, A
AHMED, T
WATSON, RC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) : 224 - 228
[120] ETOPOSIDE IN PROSTATIC-CANCER - EXPERIMENTAL STUDIES AND PHASE-II TRIAL IN PATIENTS WITH BIDIMENSIONALLY MEASURABLE DISEASE
SCHER, HI
STERNBERG, C
HESTON, WDW
WATSON, RC
NIEDZWIECKI, D
SMART, T
HOLLANDER, P
YAGODA, A
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 24 - 26